NCT01832116View on ClinicalTrials.gov

89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Ovarian NeoplasmsOvarian DiseasesAdnexal DiseasesPancreatic NeoplasmsDigestive System NeoplasmsDigestive System DiseasesPancreatic Diseases
Interventions
DRUG

89Zr-MMOT0530A

Injection of 89Zr-MMOT0530A followed by 2 or 3 PET scans at different time points

Trial Locations (2)

1081HV

VU Medical Center, Amsterdam

9713GZ

University Medical Center Groningen, Groningen

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Amsterdam UMC, location VUmc

OTHER

collaborator

Genentech, Inc.

INDUSTRY

lead

University Medical Center Groningen

OTHER

NCT01832116 - 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients | Biotech Hunter | Biotech Hunter